Home › Ocular Hypertension › Texas
Ocular Hypertension clinical trials in Texas
8 studies for Ocular Hypertension are looking for participants at sites in Texas.
Cities in Texas
iDose TR Administration in an Office-Based Surgery Setting
- Glaukos Investigative Site, Austin
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07816692A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
- Houston Eye Associates, Houston
- R and R eye research, San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07661329Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- Glaukos Clinical Site, El Paso
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
- Ophthalmology Associates, Fort Worth
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT04967989Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
RecruitingPhase 3
Ages 22 and older · All sexes · Updated Oct 20, 2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
RecruitingPhase 3
Ages 22 and older · All sexes · Updated Oct 20, 2025 · NCT07218783Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
- Wilford Hall Ambulatory Surgical Center, Lackland Air Force Base
Recruiting
Ages 18 and older · All sexes · Updated May 6, 2023 · NCT05844384Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Keystone Research, Austin
- Houston Eye Associates, North Loop, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 10, 2022 · NCT05401357From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.